Dr Francois Vaillant
Honorary (Fellow)
Department of Medical Biology (WEHI)
102 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
IAP-based biodegraders can convert necroptosis to apoptosis and eliminate cancer driving protein complexes
DOI: 10.1016/j.chembiol.2026.03.0052025
Journal article
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesis
DOI: 10.1038/s44318-025-00422-32024
Journal article
Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesis
DOI: 10.1016/j.celrep.2024.1150732024
Journal article
Ehf controls mammary alveolar lineage differentiation and is a putative suppressor of breast tumorigenesis
DOI: 10.1016/j.devcel.2024.04.0222024
Journal article
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
DOI: 10.1158/2159-8290.CD-23-04022024
Journal article
Exploring breast cancer vulnerabilities through apoptotic pathways
DOI: 10.1158/1538-7445.ADVBC23-IA262019
Journal article
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer
DOI: 10.1158/2159-8290.CD-18-1151
RECENT SCHOLARLY WORKS
2024
Journal article
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers
DOI: 10.1038/s41556-023-01315-52023
Journal article
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER breast cancer
DOI: 10.1016/j.chembiol.2023.07.0052022
Journal article
In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis
DOI: 10.1002/1878-0261.131792021
Journal article
Single cell transcriptome atlas of mouse mammary epithelial cells across development
DOI: 10.1186/s13058-021-01445-4